Published in Neuroimage on February 08, 2006
Impairment of attentional networks after 1 night of sleep deprivation. Cereb Cortex (2008) 1.47
Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception. Psychiatry Res (2007) 1.44
Dynamic PET denoising with HYPR processing. J Nucl Med (2010) 1.35
The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev (2009) 1.30
Striatal dopamine release in sequential learning. Neuroimage (2007) 1.25
rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One (2009) 1.22
Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse (2010) 1.15
Dopamine release during human emotional processing. Neuroimage (2009) 1.03
Measuring extrastriatal dopamine release during a reward learning task. Hum Brain Mapp (2011) 1.01
A linear model for estimation of neurotransmitter response profiles from dynamic PET data. Neuroimage (2011) 0.99
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PLoS One (2013) 0.98
Differential regional gray matter volumes in patients with on-line game addiction and professional gamers. J Psychiatr Res (2012) 0.98
The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging. Neuroimage (2008) 0.95
Sex differences in the brain's dopamine signature of cigarette smoking. J Neurosci (2014) 0.94
COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge. PLoS One (2013) 0.93
Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder. PLoS One (2015) 0.87
Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex. Schizophr Bull (2013) 0.82
Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers. J Psychiatry Neurosci (2010) 0.82
Cortical dopamine release during a behavioral response inhibition task. Synapse (2014) 0.81
Detection of dopamine neurotransmission in "real time". Front Neurosci (2013) 0.80
Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging. Neuroscientist (2011) 0.79
Imaging dopamine neurotransmission in live human brain. Prog Brain Res (2014) 0.77
Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment. Transl Psychiatry (2016) 0.77
No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder. Transl Psychiatry (2015) 0.76
Differential dopamine function in fibromyalgia. Brain Imaging Behav (2016) 0.76
Early-Life Stress Affects Stress-Related Prefrontal Dopamine Activity in Healthy Adults, but Not in Individuals with Psychotic Disorder. PLoS One (2016) 0.75
Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults. Front Neurosci (2016) 0.75
Increased dopamine release after working-memory updating training: Neurochemical correlates of transfer. Sci Rep (2017) 0.75
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood: an event-related FMRI study. Am J Psychiatry (2004) 1.55
Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology (2007) 1.54
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging (2008) 1.52
Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophr Res (2007) 1.44
Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry (2002) 1.35
Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biol Psychiatry (2005) 1.35
Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry (2006) 1.31
Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med (2006) 1.27
Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry (2005) 1.23
11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol (2007) 1.23
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry (2002) 1.22
Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. J Nucl Med (2006) 1.22
Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol (2006) 1.22
D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophr Res (2006) 1.19
Frontal lobe metabolic decreases with sleep deprivation not totally reversed by recovery sleep. Neuropsychopharmacology (2006) 1.19
MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiatry (2003) 1.19
Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol Psychiatry (2009) 1.17
White matter fractional anisotropy and outcome in schizophrenia. Schizophr Res (2006) 1.15
Cortical intercorrelations of frontal area volumes in schizophrenia. Neuroimage (2005) 1.15
Volume of the cingulate and outcome in schizophrenia. Schizophr Res (2005) 1.13
The thalamus and schizophrenia: current status of research. Acta Neuropathol (2008) 1.13
Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch Gen Psychiatry (2003) 1.10
A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage (2007) 1.09
Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl) (2004) 1.07
Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res (2008) 1.07
Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res (2004) 1.05
Deficient attentional modulation of the startle response in patients with schizotypal personality disorder. Am J Psychiatry (2003) 1.04
Very poor outcome schizophrenia: clinical and neuroimaging aspects. Int Rev Psychiatry (2007) 1.04
Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET. Brain Res (2005) 1.02
Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex. Am J Psychiatry (2004) 1.02
Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patients. Neuropsychobiology (2004) 1.00
Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. J Psychiatr Res (2006) 0.99
A longitudinal study of the corpus callosum in chronic schizophrenia. Schizophr Res (2009) 0.99
Metabolic disconnection between the mediodorsal nucleus of the thalamus and cortical Brodmann's areas of the left hemisphere in schizophrenia. Am J Psychiatry (2005) 0.98
Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls. BMC Psychiatry (2007) 0.98
Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression. J Affect Disord (2007) 0.97
Batch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer. Lab Chip (2012) 0.97
Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD. Psychoneuroendocrinology (2005) 0.97
Thalamus size and outcome in schizophrenia. Schizophr Res (2004) 0.97
Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am J Psychiatry (2004) 0.95
Diffusion tensor anisotropy in adolescents and adults. Neuropsychobiology (2007) 0.95
Correlations between MRI-assessed volumes of the thalamus and cortical Brodmann's areas in schizophrenia. Schizophr Res (2004) 0.95
Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage (2008) 0.95
Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr Res (2006) 0.94
Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen. Schizophr Res (2009) 0.94
The genomic psychiatry cohort: partners in discovery. Am J Med Genet B Neuropsychiatr Genet (2013) 0.94
Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr Res (2009) 0.93
Imaging monetary reward in pathological gamblers. World J Biol Psychiatry (2005) 0.93
11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI. J Nucl Med (2012) 0.93
Internal capsule size in good-outcome and poor-outcome schizophrenia. J Neuropsychiatry Clin Neurosci (2006) 0.92
Diffusion tensor anisotropy in the cingulate gyrus in schizophrenia. Neuroimage (2010) 0.91
Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia. Neuroreport (2008) 0.91
Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2011) 0.91
Cortical intercorrelations of temporal area volumes in schizophrenia. Schizophr Res (2005) 0.90
11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain. Bioorg Med Chem (2004) 0.90
FDG uptake in inferior vena cava tumor thrombus from renal cell carcinoma on positron emission tomography. Clin Nucl Med (2007) 0.90
Neuropsychological functioning in first-break, never-medicated adolescents with psychosis. J Nerv Ment Dis (2004) 0.89
Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophr Res (2007) 0.88
Age and diffusion tensor anisotropy in adolescent and adult patients with schizophrenia. Neuroimage (2009) 0.88
Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates. Nucl Med Biol (2004) 0.88
FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology (2008) 0.86
Striatal size, glucose metabolic rate, and verbal learning in normal aging. Brain Res Cogn Brain Res (2003) 0.85
The relationship between hippocampal volume and declarative memory in a population of combat veterans with and without PTSD. Ann N Y Acad Sci (2006) 0.85
Effects of sex and normal aging on regional brain activation during verbal memory performance. Neurobiol Aging (2008) 0.84
Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET. Nucl Med Biol (2012) 0.83
Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate. J Nucl Med (2005) 0.83
Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia. Am J Psychiatry (2005) 0.83
Correlations between volumes of the pulvinar, centromedian, and mediodorsal nuclei and cortical Brodmann's areas in schizophrenia. Neurosci Lett (2005) 0.83
[Not Available]. Open Neuroimag J (2009) 0.83
Frontal cortex function. Am J Psychiatry (2004) 0.83
Neuroimaging studies in post-traumatic stress disorder. Psychiatr Clin North Am (2002) 0.82
Anterior and posterior cingulate cortex volume in healthy adults: effects of aging and gender differences. Brain Res (2011) 0.82
Binding characteristics of high-affinity dopamine D2/D3 receptor agonists, 11C-PPHT and 11C-ZYY-339 in rodents and imaging in non-human primates by PET. Synapse (2004) 0.82
Functional MRI of visuospatial working memory in schizotypal personality disorder: a region-of-interest analysis. Psychol Med (2005) 0.82
Changes in relative glucose metabolic rate following cortisol administration in aging veterans with posttraumatic stress disorder: an FDG-PET neuroimaging study. J Neuropsychiatry Clin Neurosci (2009) 0.82
Brodmann area analysis of white matter anisotropy and age in schizophrenia. Schizophr Res (2011) 0.82
Metabolic thalamocortical correlations during a verbal learning task and their comparison with correlations among regional volumes. Brain Res (2006) 0.81
Anterior limb of the internal capsule in schizotypal personality disorder: fiber-tract counting, volume, and anisotropy. Schizophr Res (2012) 0.81
Serotonin transporter binding after recovery from bulimia nervosa. Int J Eat Disord (2011) 0.81
The effect of doxapram on brain imaging in patients with panic disorder. Eur Neuropsychopharmacol (2007) 0.81
Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy. Neurol India (2004) 0.79
Tc-99m pertechnetate/sestamibi subtraction scan in a case of parathyroid carcinoma. Clin Nucl Med (2008) 0.79
Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine). Nucl Med Biol (2011) 0.79
Selective attention, inhibition for repeated events and hemispheric specialization. Brain Cogn (2003) 0.78
Statistical parametric mapping and cluster counting analysis of [18F] FDG-PET imaging in traumatic brain injury. J Neurotrauma (2010) 0.77
Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study. Neuropsychobiology (2010) 0.77